- Shares Barracuda Networks, Inc. (NYSE:CUDA) gained 0.04% after posting second quarter 2018 revenues of $94 million, surpassing the Zacks Consensus Estimate of $93 million
- Merck & Co., Inc.’s (NYSE:MRK) shares gained 0.2% after the company purchased a 9.9% stake in KalVista Pharmaceuticals Inc. (NASDAQ:KALV) at a price of $8.50 per share
- AnaptysBio, Inc.’s (NASDAQ:ANAB) shares rallied 101.2% after the company announced positive results and proof-of-concept data from Phase 2a trial of it drug ANB020 In used for the treatment atopic dermatitis
- Shares of Hudson Technologies Inc. (NASDAQ:HDSN) declined 0.8% after the company lowered its third quarter 2017 earnings guidance to $0.03-$0.05 a share from $0.10 per share earlier
Barracuda Networks, Inc. (CUDA): Free Stock Analysis Report
Merck & Company, Inc. (MRK): Free Stock Analysis Report
Hudson Technologies, Inc. (HDSN): Free Stock Analysis Report
AnaptysBio, Inc. (ANAB): Free Stock Analysis Report
Original post
Zacks Investment Research